Publications by authors named "Philipp Gaertner"

Claim this Profile
I
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.
Philipp Krausewitz, Markus Essler, Florian C Gaertner, Ulrike Attenberger, Julian A Luetkens

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN).
Thomas Büttner, Milka Marinova, Florian C Gaertner, Barbara Kreppel, Leander Fritsche

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.
P Krausewitz, R A Bundschuh, F C Gaertner, M Essler, U Attenberger

Trials· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded phenotype and hippocampal involvement in a novel compound heterozygosity of adult PLA2G6 associated neurodegeneration (PARK14).
Joan Philipp Michelis, Elke Hattingen, Florian C Gaertner, Martina Minnerop, Frank Träber

Parkinsonism Relat Disord· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facial movement disorder and dopamine imaging in a patient with amphetamine abuse.
Joan Philipp Michelis, Julian Zimmermann, Janis Rebecca Bedarf, Ralph Bundschuh, Florian C Gaertner

Parkinsonism Relat Disord· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis